{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:40:45Z","timestamp":1773819645470,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.03.054","type":"journal-article","created":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T08:25:16Z","timestamp":1270196716000},"page":"F17-F22","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S5","title":["Immunopotentiation of live brucellosis vaccine by adjuvants"],"prefix":"10.1016","volume":"28","author":[{"given":"Alexander A.","family":"Denisov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia S.","family":"Korobovtseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga M.","family":"Karpova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla V.","family":"Tretyakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa V.","family":"Mikhina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arkadyi V.","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin M.","family":"Salmakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman V.","family":"Borovick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.03.054_bib0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.drudis.2008.04.010","article-title":"Vaccines against intracellular bacterial pathogens","volume":"13","author":"Titball","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/713608012","article-title":"T cell immunity to brucellosis","volume":"29","author":"Yingst","year":"2003","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.coi.2006.07.002","article-title":"Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors","volume":"18","author":"Bonneville","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1099\/00222615-37-2-100","article-title":"Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella","volume":"37","author":"Jacques","year":"1992","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1099\/00222615-43-5-344","article-title":"Outer membrane protein and rough lipopolysaccharide-specific monoclonal antibodies protect mice against Brucella ovis","volume":"43","author":"Bowden","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0040","first-page":"667","article-title":"Studies of vaccination during calfhood to prevent bovine infectious abortion","volume":"41","author":"Buck","year":"1930","journal-title":"J Agric Res"},{"issue":"3","key":"10.1016\/j.vaccine.2010.03.054_bib0045","first-page":"212","volume":"10","author":"De Vries","year":"1977","journal-title":"HLA and infectious diseases: Ir genes and natural selection\u2014tissue antigens"},{"issue":"2","key":"10.1016\/j.vaccine.2010.03.054_bib0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7589\/0090-3558-27.2.258","article-title":"Brucella abortus in bison II. Evaluation of strain 19 vaccination of pregnant cows","volume":"27","author":"Davis","year":"1991","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0055","series-title":"Proc. 85th Ann. Mtg. US Animal Health Assoc","first-page":"359","article-title":"Efficacy of vaccination of elk with strain 19 Brucella abortus","author":"Thorne","year":"1981"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0060","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2460\/ajvr.1996.57.11.1604","article-title":"Abortion and placentitis in pregnant bison (Bison bison) induced by the vaccine candidate, Brucella abortus strain RB51","volume":"57","author":"Palmer","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7589\/0090-3558-36.3.477","article-title":"Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk","volume":"36","author":"Kreeger","year":"2000","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/14760584.6.5.673","article-title":"The science of adjuvants","volume":"6","author":"Kwissa","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0075","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.2741\/2887","article-title":"Rationally designed vaccine adjuvants: separating efficacy from toxicity","volume":"13","author":"Hauguel","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"1","author":"Reed","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2005.05.005","article-title":"Vaccinology at the beginning of the 21st century","volume":"17","author":"Wack","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0264-410X(92)90389-2","article-title":"Cytokines as immunological adjuvants","volume":"10","author":"Hearth","year":"1992","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.054_bib0095","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.vaccine.2008.12.049","article-title":"Amended recombinant cells (ARCs\u2122) expressing bovine IFN-\u03b3: an economical and highly effective adjuvant system","volume":"27","author":"Gaertner","year":"2009","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2010.03.054_bib0100","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.vaccine.2008.03.089","article-title":"The effects of IL-6 and TNF-\u03b1 as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination","volume":"26","author":"Su","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0161-5890(02)00020-2","article-title":"Cytokine expression by attenuated intracellular bacteria regulates the immune response to infection: the Salmonella model","volume":"38","author":"al-Ramadi","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0110","series-title":"Abstracts of All-Union Conference \u201cUrgent Questions of Epizootology\u201d","first-page":"66","article-title":"Testing of vaccine strain 82-PS on large horned cattle","author":"Salmakov","year":"1983"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0115","unstructured":"Salmakov KM, Belozerova GA. SU Patent (Soviet Union) #1,824,737, March 05; 1994. Live vaccine for prophylaxis of cattle brucellosis from B. abortus 82-PS strain."},{"key":"10.1016\/j.vaccine.2010.03.054_bib0120","series-title":"Diagnostics, treatment and prophylaxis of infectious diseases. Biotechnology. Veterinary","first-page":"297","article-title":"Study of vaccine immunogenicity of vaccine strain B. abortus 82-PS on guinea pigs at combined application with immunomodulators","author":"Shuralev","year":"1999"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0125","first-page":"3","article-title":"Polyoxydonium\u2014immunomodulator of the newest generation: results of 3-year clinical application","volume":"3","author":"Petrov","year":"1999","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0130","series-title":"Diagnostics, treatment and prophylaxis of infectious diseases. Biotechnology. Veterinary","first-page":"66","article-title":"Effectiveness of application of immunomodulators at brucellosis vaccinoprophylaxis","author":"Shuralev","year":"1999"},{"issue":"6","key":"10.1016\/j.vaccine.2010.03.054_bib0135","first-page":"697","article-title":"Comparative study of the antiviral activity of natural double-stranded RNAs in experimental tick-borne encephalitis","volume":"30","author":"Knoroz MIu","year":"1985","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0140","series-title":"The theory and practical application of adjuvants","first-page":"287","article-title":"Ribi adjuvants: chemistry, biology and utility in vaccines for human and veterinary medicine","author":"Rudbach","year":"1995"},{"issue":"9","key":"10.1016\/j.vaccine.2010.03.054_bib0145","first-page":"1403","article-title":"Recombinant human lymphotoxin: synthesis in Escherichia coli, purification and some properties","volume":"60","author":"Denisov","year":"1995","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0150","first-page":"34","article-title":"Immunoregulating activity of recombinant human lymphotoxin","volume":"4","author":"Denisov","year":"1996","journal-title":"Immunology (Mosc)"},{"key":"10.1016\/j.vaccine.2010.03.054_bib0155","series-title":"Enhancing Brucellosis Vaccines, Vaccine Delivery and Surveillance Diagnostics for Elk and Bison in the Greater Yellowstone Area: A Technical Report from a Working Symposium","author":"United States Animal Health Association","year":"2006"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T14:13:45Z","timestamp":1711376025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10004548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":31,"alternative-id":["S0264410X10004548"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.054","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}